Central Vascular Access Catheter

Central Vascular Access Catheter Market Outlook

The global Central Vascular Access Catheter market is anticipated to reach approximately USD 3.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period from 2025 to 2035. The rising prevalence of chronic diseases such as cancer, renal failure, and infectious diseases is a primary driver of market growth. Additionally, the increasing adoption of advanced medical technologies and the growing number of surgical procedures necessitate effective vascular access solutions. The demand for minimally invasive procedures is further propelling the market as healthcare providers seek to improve patient outcomes and reduce complications associated with vascular access. Moreover, an expansion in healthcare infrastructure in developing regions enhances the accessibility of vascular access catheters, thereby contributing to market growth.

Growth Factor of the Market

The growth of the Central Vascular Access Catheter market is primarily fueled by the increasing incidence of chronic illnesses, which require prolonged intravenous therapy for treatment. As conditions such as cancer and kidney disease become more prevalent, the demand for effective vascular access solutions rises, promoting the utilization of central catheters. Additionally, advancements in catheter technology, including improved materials and designs, help minimize complications such as infections and thrombosis, further supporting their adoption in clinical settings. The rising number of surgical procedures, particularly in outpatient settings, also adds to the demand for these devices, as healthcare providers aim to facilitate efficient patient care. Another significant growth factor is the increasing awareness and training programs for healthcare professionals regarding the proper use of central venous catheters, which enhances patient safety and comfort during treatment.

Key Highlights of the Market

• The Central Vascular Access Catheter market is projected to grow at a CAGR of 6.8% from 2025 to 2035.
• North America dominates the market, accounting for over 40% of the global market share.
• Peripherally Inserted Central Catheters (PICCs) are expected to witness the highest growth due to their versatility and ease of use.
• Innovations in catheter materials, such as antimicrobial coatings, are enhancing patient outcomes and reducing infection rates.
• The growing preference for outpatient surgical procedures is driving the demand for vascular access solutions across various healthcare settings.

By Product Type

Peripherally Inserted Central Catheters:

Peripherally Inserted Central Catheters (PICCs) represent a significant segment of the Central Vascular Access Catheter market due to their versatility and ease of insertion. PICCs are designed for long-term use, allowing for extended intravenous therapy, which is particularly beneficial for patients requiring chemotherapy or long-term antibiotics. The growing acceptance of PICCs in both inpatient and outpatient settings is accelerating their adoption, as they offer a reliable solution for vascular access with a lower risk of complications compared to traditional central lines. Moreover, advancements in PICC technology, such as enhanced biocompatibility and reduced infection rates, are contributing to their increasing utilization among healthcare providers.

Tunneled Central Catheters:

Tunneled Central Catheters are specifically designed for long-term access, often used in patients undergoing repeated treatments such as chemotherapy or dialysis. These catheters are surgically placed and tunneled under the skin, providing a stable access point while minimizing the risk of infection. The market for tunneled catheters is witnessing growth as the demand for long-term vascular access solutions increases. Their ability to remain in place for extended periods without frequent replacements makes them a preferred choice for healthcare providers. Additionally, the improved design and materials used in these catheters reduce complications and enhance patient safety, further driving their market acceptance.

Non-Tunneled Central Catheters:

Non-Tunneled Central Catheters are primarily used for short-term access, making them ideal for emergency situations or acute care settings. This type of catheter can be quickly inserted, providing immediate vascular access for critical interventions. The increasing incidence of emergency medical procedures drives the demand for non-tunneled catheters, as they are crucial in providing rapid therapy to patients. Despite their short-term usage, advancements in non-tunneled catheter technology are focused on enhancing patient comfort and minimizing infection risks. As healthcare systems continue to optimize their emergency response protocols, the demand for non-tunneled central catheters is expected to remain strong.

Implanted Port Catheters:

Implanted Port Catheters are designed for patients who require long-term vascular access but prefer a less visible and more comfortable solution. These catheters are surgically implanted beneath the skin and connected to a central vein, allowing for easy access without the need for external tubing. The growing incidence of chronic illnesses requiring prolonged therapy, such as cancer, has significantly increased the demand for implanted ports. Their discreet nature and reduced risk of infection compared to external devices make them particularly appealing to patients. As healthcare providers adopt more patient-centered approaches, the use of implanted port catheters is anticipated to rise, furthering their significance in the market.

Hemodialysis Catheters:

Pioneering in renal care, Hemodialysis Catheters serve a critical function for patients requiring regular dialysis treatments. These catheters are strategically designed to facilitate blood access for hemodialysis procedures, ensuring efficient treatment delivery. Given the rising prevalence of chronic kidney diseases worldwide, the demand for hemodialysis catheters is experiencing notable growth. Furthermore, innovations in catheter design aimed at increasing blood flow rates and reducing complications like thrombosis and infection are enhancing their market appeal. The importance of reliable and durable access points for dialysis patients drives ongoing investments in this segment, solidifying its critical role in the Central Vascular Access Catheter market.

By Application

Chemotherapy:

Chemotherapy is one of the key applications driving the demand for Central Vascular Access Catheters. These devices are essential for administering chemotherapeutic agents, as they allow for the safe and efficient delivery of medications directly into the bloodstream. Patients undergoing chemotherapy often require multiple infusions over extended periods, making reliable vascular access critical. The increasing incidence of cancer worldwide, along with the growing number of patients requiring long-term treatment, bolsters the market for catheters used in chemotherapy. Additionally, advancements in catheter technology that minimize complications and improve comfort are influencing their widespread adoption in oncology settings.

Parenteral Nutrition:

Parenteral nutrition, which involves delivering nutrients directly into the bloodstream, is another significant application for Central Vascular Access Catheters. This method is crucial for patients unable to consume food orally due to various medical conditions. The rising prevalence of gastrointestinal disorders and the increasing number of patients requiring nutritional support have led to heightened demand for vascular access solutions in this area. Central venous catheters facilitate safe and effective delivery of parenteral nutrition, ensuring patients receive adequate nourishment. The growing emphasis on patient-centered healthcare and personalized nutrition solutions is expected to further drive the adoption of these catheters in clinical settings.

Infectious Diseases:

In recent years, the role of Central Vascular Access Catheters in treating infectious diseases has become increasingly prominent. These catheters are essential for administering intravenous antibiotics and other therapeutic agents to patients with severe infections that require close monitoring and ongoing treatment. With the emergence of antibiotic-resistant infections and the need for aggressive treatment regimens, the demand for effective vascular access solutions is on the rise. Healthcare providers are recognizing the importance of utilizing high-quality catheters that reduce infection risks while providing reliable access for prolonged therapy. This growing focus on combating infectious diseases is likely to contribute to the expansion of the central vascular access catheter market.

Others:

In addition to chemotherapy, parenteral nutrition, and infectious diseases, several other applications contribute to the demand for Central Vascular Access Catheters. These include procedures such as blood transfusions, fluid resuscitation, and the administration of various medications for chronic illnesses. The versatility of central venous catheters enables their use across a wide range of medical scenarios, enhancing their appeal to healthcare providers. As the healthcare landscape evolves and the need for efficient vascular access solutions continues to grow, the market for catheters used in these diverse applications is expected to expand further. Factors such as technological advancements and increased clinician awareness will play a crucial role in driving this segment's growth.

By Distribution Channel

Hospitals:

Hospitals represent the largest distribution channel for Central Vascular Access Catheters, owing to their extensive use in acute care settings. The demand for vascular access solutions in hospitals is primarily driven by the need for reliable and efficient access for intravenous therapies, particularly in emergency and surgical departments. Hospitals often require a wide variety of catheters to cater to different patient needs, leading to bulk purchasing agreements with suppliers. Additionally, as healthcare providers focus on improving patient outcomes, the adoption of advanced catheter technologies that reduce complications and enhance safety is becoming increasingly important. The ongoing investments in healthcare infrastructure and the rising number of hospital admissions will continue to bolster this distribution channel.

Specialty Clinics:

Specialty clinics, including oncology, nephrology, and infectious disease clinics, are emerging as significant distribution channels for Central Vascular Access Catheters. These clinics often cater to patients requiring specialized treatments that necessitate reliable vascular access solutions. The growing trend of outpatient care and the increasing number of specialized treatment centers are driving the demand for catheters in these settings. Additionally, as healthcare providers aim to enhance patient comfort and reduce the need for hospitalization, the adoption of central venous catheters in specialty clinics is expected to rise. This segment's growth is further supported by the focus on personalized care and the need for continuous monitoring and treatment in specialty settings.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are becoming a critical distribution channel for Central Vascular Access Catheters, particularly as the trend toward outpatient surgeries continues to grow. These facilities often perform various procedures that require effective vascular access, making them an essential market for catheter suppliers. The convenience and efficiency of ASCs encourage the use of central venous catheters, as they allow for quick recovery times and streamlined patient care. Additionally, the increasing patient preference for outpatient procedures and the efforts of healthcare systems to reduce costs further enhance the demand for catheters in this distribution channel. As ASCs continue to gain popularity, their role in the Central Vascular Access Catheter market is expected to expand significantly.

Others:

Other distribution channels, including online platforms and medical supply distributors, play a vital role in the Central Vascular Access Catheter market. The convenience of online purchasing is increasingly appealing to healthcare facilities seeking to streamline procurement processes. Additionally, medical supply distributors often offer a wide range of products, making them a one-stop solution for healthcare providers. The market's evolution, driven by technological advancements and the growing digitalization of healthcare, is expected to enhance the accessibility and distribution of central venous catheters. Furthermore, the rise of telehealth and remote patient monitoring may contribute to the expansion of alternative distribution channels, allowing for greater flexibility in acquiring essential medical devices.

By Material Type

Polyurethane:

Polyurethane is one of the predominant materials used in the manufacturing of Central Vascular Access Catheters. Its unique properties, including biocompatibility, flexibility, and durability, make it an ideal choice for catheter applications. Polyurethane catheters are known for their resistance to kinking and tearing, providing reliable performance during use. Additionally, the material's susceptibility to modifications allows for the incorporation of antimicrobial coatings, which help reduce infection risks associated with catheter use. The growing preference for polyurethane catheters, driven by their enhanced performance characteristics and safety profiles, positions them as a leading material type in the market.

Silicone:

Silicone is another widely used material in Central Vascular Access Catheters, favored for its biocompatibility and softness, which enhances patient comfort. Silicone catheters are particularly beneficial for long-term use, as they are less likely to cause irritation or discomfort at the insertion site. Their inherent flexibility promotes ease of insertion and reduces the risk of complications such as thrombosis. The increasing demand for silicone catheters is being driven by a growing focus on improving patient experiences during treatment. Innovations in silicone catheter technology, such as the development of anti-microbial and drug-eluting versions, further enhance their appeal in the market, making them a strong contender alongside polyurethane catheters.

Others:

Other materials used in the production of Central Vascular Access Catheters include various polymers and composites designed to enhance performance and safety. These alternative materials may offer specific benefits, such as improved resistance to certain chemicals or enhanced flexibility. The ongoing research and development of novel materials aim to address limitations associated with traditional catheter materials, leading to innovations that minimize infection risks and improve overall patient outcomes. As the healthcare industry continues to prioritize advancements in medical technology, the segment of catheters made from alternative materials is expected to grow, driven by the demand for specialized solutions tailored to diverse clinical needs.

By Region

North America is the largest market for Central Vascular Access Catheters, accounting for over 40% of the global market share. This dominance is attributed to the advanced healthcare infrastructure, high prevalence of chronic diseases, and a well-established medical device industry. Additionally, the presence of leading market players and continuous innovation in catheter technology contributes to the growth of the North American market. The region is projected to grow at a CAGR of 6.5%, driven by the increasing adoption of minimally invasive procedures and the rising demand for long-term vascular access solutions in outpatient settings. Furthermore, healthcare policies promoting patient safety and quality of care are expected to enhance the market landscape in North America.

Europe holds the second-largest share of the Central Vascular Access Catheter market, with a strong focus on improving patient outcomes and advancing medical technology. Contributing factors include the growing elderly population, increasing incidence of chronic diseases, and an emphasis on outpatient treatment options. The European market is projected to exhibit a CAGR of 6.2%, driven by the rising demand for innovative catheter solutions and the expansion of healthcare services. Additionally, strategic collaborations between healthcare providers and medical device manufacturers are fostering the development of advanced catheter technologies. As healthcare facilities continue to invest in improving patient care, the demand for central vascular access catheters in Europe is expected to grow significantly.

Opportunities

The Central Vascular Access Catheter market presents numerous opportunities for growth driven by technological advancements and increasing awareness of patient safety. Innovations in catheter design, such as the development of antimicrobial and bioactive coatings, are enhancing the efficacy of these devices in preventing infections, which is a significant concern in vascular access procedures. Furthermore, the integration of smart technologies, such as real-time monitoring systems, holds the potential to revolutionize patient care by providing healthcare professionals with valuable data during treatment. As healthcare providers increasingly prioritize patient outcomes and safety, the demand for advanced catheter solutions is expected to rise, creating a robust market for specialized products and services. Additionally, the ongoing trend towards outpatient and home-based care opens new avenues for catheter utilization, particularly in managing chronic diseases.

Furthermore, emerging markets in Asia Pacific and Latin America are presenting vast opportunities for manufacturers and suppliers of Central Vascular Access Catheters. With improvements in healthcare infrastructure and rising disposable incomes, these regions are experiencing a growing demand for advanced medical technologies. As healthcare systems invest in expanding access to quality care, the need for effective vascular access solutions will also increase. Additionally, collaborations between local distributors and global manufacturers can facilitate the introduction of innovative products tailored to meet regional healthcare needs. By leveraging emerging market potential, stakeholders can position themselves competitively and capitalize on the growing demand for central vascular access solutions in these regions.

Threats

Despite the promising growth prospects of the Central Vascular Access Catheter market, several threats could impede its progress. One of the primary challenges is the increasing prevalence of catheter-related infections, which poses significant risks to patient safety and can lead to severe complications. The rise in antibiotic-resistant bacteria necessitates ongoing vigilance and improvement in catheter design and care protocols to mitigate infection risks. Additionally, stringent regulatory requirements for medical devices can create hurdles for manufacturers seeking to introduce new products to the market. The complexity of obtaining regulatory approval, coupled with the high costs associated with compliance, may deter smaller companies from entering the market and limit innovation.

Another threat includes the potential for product recalls due to safety concerns or manufacturing defects, which can undermine consumer confidence and negatively impact sales. The competitive landscape of the market is also intensifying, with numerous players vying for market share, leading to pricing pressures that could affect profit margins. Manufacturers must remain agile and responsive to market trends while continuously investing in research and development to differentiate their products. Overall, addressing these threats is crucial for maintaining a stable growth trajectory in the Central Vascular Access Catheter market.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Smiths Medical
• Medtronic
• Teleflex Incorporated
• Boston Scientific Corporation
• Fresenius Kabi AG
• Vygon S.A.
• Access Scientific, Inc.
• AngioDynamics, Inc.
• Cook Medical
• Cardinal Health
• Halyard Health, Inc.
• Ino Therapeutics, LLC
• Terumo Corporation
• Merit Medical Systems, Inc.

The competitive landscape of the Central Vascular Access Catheter market is characterized by a mix of established players and emerging companies, all striving to innovate and capture market share. Leading companies, such as BD and Medtronic, leverage their extensive research and development capabilities to introduce advanced catheter technologies that enhance patient safety and improve clinical outcomes. These industry giants often engage in strategic partnerships, acquisitions, and collaborations to expand their product portfolios and reach new markets. Additionally, ongoing investments in manufacturing capabilities and supply chain optimization allow these companies to maintain operational efficiency and responsiveness to market demands.

Small to mid-sized companies, such as Access Scientific and AngioDynamics, are also making significant strides in the market by focusing on niche segments and specialized catheter solutions. These players often prioritize innovation, offering unique features and benefits that differentiate their products from those of larger competitors. The agility of these companies allows them to adapt quickly to changing market conditions and address specific customer needs effectively. As the demand for advanced vascular access solutions continues to rise, the competition among both large and small players is expected to intensify, fostering an environment of innovation and product development in the Central Vascular Access Catheter market.

Key companies such as Teleflex and Smiths Medical are exemplifying the trend of development in the Central Vascular Access Catheter market by launching new products designed to reduce infection rates and enhance patient comfort. For instance, Teleflex's introduction of catheters with advanced antimicrobial properties reflects the industry shift towards prioritizing patient safety while addressing growing concerns regarding catheter-related infections. Furthermore, these companies are actively participating in clinical research and trials to validate the efficacy and safety of their products, which is crucial for gaining regulatory approvals and building trust among healthcare providers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cardinal Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Ino Therapeutics, LLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Access Scientific, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Merit Medical Systems, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Central Vascular Access Catheter Market, By Application
    • 6.1.1 Chemotherapy
    • 6.1.2 Parenteral Nutrition
    • 6.1.3 Infectious Diseases
    • 6.1.4 Others
  • 6.2 Central Vascular Access Catheter Market, By Product Type
    • 6.2.1 Peripherally Inserted Central Catheters
    • 6.2.2 Tunneled Central Catheters
    • 6.2.3 Non-Tunneled Central Catheters
    • 6.2.4 Implanted Port Catheters
    • 6.2.5 Hemodialysis Catheters
  • 6.3 Central Vascular Access Catheter Market, By Material Type
    • 6.3.1 Polyurethane
    • 6.3.2 Silicone
    • 6.3.3 Others
  • 6.4 Central Vascular Access Catheter Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Central Vascular Access Catheter Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Central Vascular Access Catheter market is categorized based on

By Product Type

• Peripherally Inserted Central Catheters
• Tunneled Central Catheters
• Non-Tunneled Central Catheters
• Implanted Port Catheters
• Hemodialysis Catheters

By Application

• Chemotherapy
• Parenteral Nutrition
• Infectious Diseases
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Material Type

• Polyurethane
• Silicone
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Smiths Medical
• Medtronic
• Teleflex Incorporated
• Boston Scientific Corporation
• Fresenius Kabi AG
• Vygon S.A.
• Access Scientific, Inc.
• AngioDynamics, Inc.
• Cook Medical
• Cardinal Health
• Halyard Health, Inc.
• Ino Therapeutics, LLC
• Terumo Corporation
• Merit Medical Systems, Inc.